초록

The present invention provides methods for cellular seeding onto three-dimensional fibroblast constructs, three-dimensional fibroblast constructs seeded with muscle cells, and uses therefore.

대표청구항 ▼

1. A construct comprising cardiomyocytes, cardiac stem cells, or progenitors thereof adhered as a 1-2 cell thick layer over a layer of fibroblasts on (a) the top surface of a three dimensional fibroblast construct (3DFC), wherein the bottom surface of the 3DFC does not have cardiomyocytes, cardiac s

1. A construct comprising cardiomyocytes, cardiac stem cells, or progenitors thereof adhered as a 1-2 cell thick layer over a layer of fibroblasts on (a) the top surface of a three dimensional fibroblast construct (3DFC), wherein the bottom surface of the 3DFC does not have cardiomyocytes, cardiac stem cells, or progenitors thereof adhered to it,(b) the bottom surface of the three dimensional fibroblast construct (3DFC), wherein the top surface of the 3DFC does not have cardiomyocytes, cardiac stem cells, or progenitors thereof adhered to it; or(c) the top and the bottom surface of the 3DFC;wherein the cells seeded on the 3DFC surface are capable of initiating spontaneous contractions across the full 3DFC, and wherein the entire construct is capable of synchronized contraction; and wherein the cardiomyocytes, cardiac stem cells, or progenitors thereof are seeded on the surface at a density of between 0.5×106 cells/cm2 and 5×106 cells/cm2 and the cardiomyocytes, cardiac stem cells, or progenitors thereof are present on the surface in a ratio of between about 1:10 and about 10:1 with fibroblasts on the 3DFC. 2. The construct of claim 1, wherein the cardiomyocytes, cardiac stem cells, or progenitors thereof are seeded on the top and/or bottom surface at a density of between 1.3×106 cells/cm2 and 5×106 cells/cm2. 3. The construct of claim 1, wherein the cardiomyocytes, cardiac stem cells, or progenitors thereof are seeded on the top and/or bottom surface at a density of between 1.5×106 cells/cm2 and 3×106 cells/cm2. 4. The construct of claim 1, wherein the cardiomyocytes or cardiac stem cells, or progenitors thereof are of human origin. 5. The construct of claim 1, wherein the cardiomyocytes or cardiac stem cells, or progenitors thereof are engineered to express one or more of thymosin beta-4 (TB4), akt murine thymoma viral oncogene homolog (AKT1), stroma cell-derived factor-1 alpha (SDF-1), and hepatocyte growth factor (HGF). 6. The construct of claim 1, wherein the cardiomyocytes, cardiac stem cells, or progenitors thereof are present on the top and/or bottom surface in a ratio of between about 1:5 and about 5:1 with fibroblasts on the 3DFC.